{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T02:37:49Z","timestamp":1789958269676,"version":"4.0.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.clgc.2016.03.005","type":"journal-article","created":{"date-parts":[[2016,3,10]],"date-time":"2016-03-10T20:31:34Z","timestamp":1457641894000},"page":"518-523","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Prognostic Factors of Adjuvant Taxane, Cisplatin, and 5-Fluorouracil Chemotherapy for Patients With Penile Squamous Cell Carcinoma After Regional Lymphadenectomy"],"prefix":"10.1016","volume":"14","author":[{"given":"Andrea","family":"Necchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4444-9526","authenticated-orcid":false,"given":"Salvatore","family":"Lo Vullo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Nicolai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Raggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Giannatempo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Colecchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Catanzaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tullio","family":"Torelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Piva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Biasoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Stagni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Mariani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Salvioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clgc.2016.03.005_bib1","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1093\/annonc\/mds635","article-title":"Penile cancer: current therapy and future directions","volume":"24","author":"Sonpavde","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clgc.2016.03.005_bib2","series-title":"TNM Classification of Malignant Tumours","year":"2009"},{"key":"10.1016\/j.clgc.2016.03.005_bib3","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.ucl.2011.07.004","article-title":"Lymphadenectomy in penile cancer","volume":"38","author":"Horenblas","year":"2011","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.clgc.2016.03.005_bib4","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.ucl.2010.04.010","article-title":"Chemotherapy for penile and urethral carcinoma","volume":"37","author":"Trabulsi","year":"2010","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.clgc.2016.03.005_bib5","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.eururo.2014.10.017","article-title":"EAU guidelines on penile cancer: 2014 update","volume":"67","author":"Hakenberg","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2016.03.005_bib6","doi-asserted-by":"crossref","first-page":"823","DOI":"10.3109\/02841868809094366","article-title":"Adjuvant and neoadjuvant vincristine, bleomycin, and methotrexate for inguinal metastases from squamous cell carcinoma of the penis","volume":"27","author":"Pizzocaro","year":"1988","journal-title":"Acta Oncol"},{"key":"10.1016\/j.clgc.2016.03.005_bib7","first-page":"524","article-title":"Radiotherapy for node positive penile cancer: experience of the Leeds teaching hospitals","volume":"186","author":"Franks","year":"2011","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.clgc.2016.03.005_bib8","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.clgc.2015.07.009","article-title":"A\u00a0combination of cisplatin and 5-fluorouracil with a taxane in patients who underwent lymph node dissection for nodal metastases from squamous cell carcinoma of the penis: treatment outcome and survival analyses in neoadjuvant and adjuvant settings","volume":"14","author":"Nicolai","year":"2016","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.clgc.2016.03.005_bib9","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.clgc.2014.08.002","article-title":"Immunohistochemistry to enhance prognostic allocation and guide decision-making of patients with advanced urothelial cancer receiving first-line chemotherapy","volume":"13","author":"Necchi","year":"2015","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.clgc.2016.03.005_bib10","first-page":"977","article-title":"The relationship between characteristics of inguinal lymph nodes and pelvic lymph node involvement in penile squamous cell carcinoma: a single institution experience","volume":"191","author":"Lughezzani","year":"2014","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.clgc.2016.03.005_bib11","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.1200\/JCO.2010.29.5477","article-title":"Neoadjuvant paclitaxel, ifosfamide, and cisplatin chemotherapy for metastatic penile cancer: a phase II study","volume":"28","author":"Pagliaro","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clgc.2016.03.005_bib12","unstructured":"National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology; penile cancer, version 3.2105. Available at: http:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/penile.pdf. Accessed: January 2,\u00a02016."},{"issue":"suppl 6","key":"10.1016\/j.clgc.2016.03.005_bib13","article-title":"Treatment of metastatic penile cancer in the adjuvant setting with ifosfamide, paclitaxel, and cisplatin: a single institution experience","volume":"31","author":"O'Reilly","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clgc.2016.03.005_bib14","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1038\/bjc.2013.620","article-title":"Phase II trial of docetaxel, cisplatin and 5FU chemotherapy in locally advanced and metastatic penis cancer (CRUK\/09\/001)","volume":"109","author":"Nicholson","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clgc.2016.03.005_bib15","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.clgc.2014.06.005","article-title":"Neoadjuvant taxane-based combination chemotherapy in patients with advanced penile cancer","volume":"13","author":"Djajadiningrat","year":"2015","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.clgc.2016.03.005_bib16","doi-asserted-by":"crossref","first-page":"496e17","DOI":"10.1016\/j.urolonc.2015.05.008","article-title":"Adjuvant chemotherapy is associated with improved overall survival in pelvic node-positive penile cancer after lymph node dissection: a multi-institutional study","volume":"33","author":"Sharma","year":"2015","journal-title":"Urol Oncol"},{"key":"10.1016\/j.clgc.2016.03.005_bib17","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/bju.12946","article-title":"Prognostic factors influencing survival from regionally advanced squamous cell carcinoma of the penis after preoperative chemotherapy","volume":"117","author":"Dickstein","year":"2016","journal-title":"BJU Int"},{"key":"10.1016\/j.clgc.2016.03.005_bib18","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.urolonc.2013.10.007","article-title":"Prognostic risk stratification from individual patient level data for men with advanced penile squamous cell carcinoma receiving first-line systemic therapy","volume":"32","author":"Pond","year":"2014","journal-title":"Urol Oncol"},{"key":"10.1016\/j.clgc.2016.03.005_bib19","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1136\/jclinpath-2011-200429","article-title":"Expression of p53, p21, and cyclin D1 in penile cancer: p53 predicts poor prognosis","volume":"65","author":"Gunia","year":"2012","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.clgc.2016.03.005_bib20","first-page":"81","article-title":"p53 as a new prognostic factor for lymph node metastasis in penile carcinoma: analysis of 82 patients treated with amputation and bilateral lymphadenectomy","volume":"168","author":"Lopes","year":"2002","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.clgc.2016.03.005_bib21","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ucl.2015.08.012","article-title":"The emerging role and promise of biomarkers in penile cancer","volume":"46","author":"Vuichoud","year":"2016","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.clgc.2016.03.005_bib22","doi-asserted-by":"crossref","first-page":"5219","DOI":"10.1158\/0008-5472.CAN-15-1004","article-title":"Genomic profiling of penile squamous cell carcinoma reveals new opportunities for targeted therapy","volume":"75","author":"McDaniel","year":"2015","journal-title":"Cancer Res"},{"key":"10.1016\/j.clgc.2016.03.005_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1634\/theoncologist.2015-0241","article-title":"Comprehensive genomic profiling of advanced penile carcinoma suggests a high frequency of clinically relevant genomic alterations","volume":"21","author":"Ali","year":"2016","journal-title":"Oncologist"},{"issue":"suppl","key":"10.1016\/j.clgc.2016.03.005_bib24","article-title":"Gene expression profiling to improve prognostic stratification of men with advanced penile squamous cell cancer (PSS) receiving first-line systemic therapy","volume":"33","author":"Mehta","year":"2015","journal-title":"J\u00a0Clin Oncol"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767316300593?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767316300593?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T11:25:41Z","timestamp":1761564341000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767316300593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S1558767316300593"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2016.03.005","relation":{},"ISSN":["1558-7673"],"issn-type":[{"value":"1558-7673","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic Factors of Adjuvant Taxane, Cisplatin, and 5-Fluorouracil Chemotherapy for Patients With Penile Squamous Cell Carcinoma After Regional Lymphadenectomy","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2016.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}